nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Oedema—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Perflutren—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Perflutren—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Perflutren—Shock—Prednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Perflutren—Cough—Triamcinolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Perflutren—Convulsion—Triamcinolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Perflutren—Tachycardia—Prednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Perflutren—Convulsion—Methylprednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Perflutren—Hypertension—Triamcinolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Perflutren—Hypertension—Methylprednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Perflutren—Myalgia—Triamcinolone—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Perflutren—Myalgia—Methylprednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Perflutren—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Perflutren—Eye disorder—Prednisone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Perflutren—Flushing—Prednisone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Perflutren—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Perflutren—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Perflutren—Discomfort—Triamcinolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Perflutren—Discomfort—Methylprednisolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Perflutren—Dry mouth—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Perflutren—Angioedema—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Perflutren—Angioedema—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Perflutren—Angiopathy—Prednisone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Perflutren—Immune system disorder—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Perflutren—Malaise—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Perflutren—Malaise—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Perflutren—Oedema—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Perflutren—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Perflutren—Vertigo—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Perflutren—Vertigo—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Perflutren—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Perflutren—Syncope—Dexamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Perflutren—Syncope—Betamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Perflutren—Arrhythmia—Prednisone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Perflutren—Shock—Triamcinolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Perflutren—Shock—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Perflutren—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Perflutren—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Perflutren—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Perflutren—Paraesthesia—Prednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Perflutren—Tachycardia—Triamcinolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Perflutren—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Perflutren—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Perflutren—Erythema—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Perflutren—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Perflutren—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Perflutren—Convulsion—Dexamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Perflutren—Convulsion—Betamethasone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Perflutren—Hypertension—Betamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Perflutren—Hypertension—Dexamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Perflutren—Myalgia—Betamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Perflutren—Myalgia—Dexamethasone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Perflutren—Discomfort—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Perflutren—Discomfort—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Perflutren—Hypotension—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Perflutren—Pain—Prednisolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Perflutren—Vision blurred—Prednisone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Perflutren—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Perflutren—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Perflutren—Oedema—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Perflutren—Oedema—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Perflutren—Ill-defined disorder—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Perflutren—Paraesthesia—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Perflutren—Feeling abnormal—Prednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Perflutren—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Perflutren—Shock—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Shock—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Agitation—Prednisone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Perflutren—Tachycardia—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Perflutren—Tachycardia—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Perflutren—Angioedema—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Perflutren—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Perflutren—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Perflutren—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Perflutren—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Perflutren—Malaise—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Perflutren—Vertigo—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Perflutren—Syncope—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Perflutren—Urticaria—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Perflutren—Fatigue—Triamcinolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Perflutren—Fatigue—Methylprednisolone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Perflutren—Pain—Triamcinolone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Perflutren—Loss of consciousness—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Perflutren—Hypotension—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Perflutren—Hypotension—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Perflutren—Convulsion—Prednisone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Perflutren—Hypertension—Prednisone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Perflutren—Chills—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Perflutren—Arthralgia—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Perflutren—Myalgia—Prednisone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Perflutren—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Perflutren—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Perflutren—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Perflutren—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Perflutren—Paraesthesia—Betamethasone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Perflutren—Discomfort—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Perflutren—Erythema—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Perflutren—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Perflutren—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Perflutren—Dyspepsia—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Perflutren—Urticaria—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Perflutren—Urticaria—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Perflutren—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Perflutren—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Perflutren—Oedema—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Perflutren—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Perflutren—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Perflutren—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Perflutren—Back pain—Methotrexate—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Perflutren—Fatigue—Betamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Perflutren—Fatigue—Dexamethasone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Perflutren—Shock—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Perflutren—Pain—Betamethasone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Perflutren—Pain—Dexamethasone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Perflutren—Nervous system disorder—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Perflutren—Tachycardia—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Perflutren—Skin disorder—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Perflutren—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Perflutren—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Perflutren—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Perflutren—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Perflutren—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Perflutren—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Perflutren—Malaise—Methotrexate—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Perflutren—Vertigo—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Perflutren—Urticaria—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Perflutren—Urticaria—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Perflutren—Dizziness—Prednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Asthenia—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Abdominal pain—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Body temperature increased—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Abdominal pain—Dexamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Body temperature increased—Betamethasone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Asthenia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Perflutren—Paraesthesia—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Perflutren—Pruritus—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Perflutren—Cough—Methotrexate—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Perflutren—Pruritus—Methylprednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Perflutren—Convulsion—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Perflutren—Dyspepsia—Prednisone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Perflutren—Chest pain—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Perflutren—Myalgia—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Perflutren—Rash—Prednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Perflutren—Dermatitis—Prednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Perflutren—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Perflutren—Fatigue—Prednisone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Perflutren—Headache—Prednisolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Perflutren—Discomfort—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Perflutren—Dizziness—Triamcinolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Perflutren—Dizziness—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Perflutren—Feeling abnormal—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Perflutren—Asthenia—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Perflutren—Asthenia—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Perflutren—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Perflutren—Nausea—Prednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Perflutren—Pruritus—Dexamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Perflutren—Pruritus—Betamethasone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Perflutren—Vomiting—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Perflutren—Vomiting—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Perflutren—Rash—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Perflutren—Dermatitis—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Perflutren—Rash—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Perflutren—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Perflutren—Urticaria—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Perflutren—Headache—Triamcinolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Perflutren—Headache—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Perflutren—Body temperature increased—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Perflutren—Abdominal pain—Prednisone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Perflutren—Diarrhoea—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Perflutren—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Perflutren—Hypotension—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Perflutren—Dizziness—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Perflutren—Dizziness—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Perflutren—Nausea—Triamcinolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Perflutren—Nausea—Methylprednisolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Perflutren—Hypersensitivity—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Perflutren—Vomiting—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Perflutren—Vomiting—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Perflutren—Rash—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Perflutren—Rash—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Perflutren—Dermatitis—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Perflutren—Dermatitis—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Perflutren—Fatigue—Methotrexate—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Perflutren—Headache—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Perflutren—Headache—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Perflutren—Asthenia—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Perflutren—Pain—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Perflutren—Pruritus—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Perflutren—Diarrhoea—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Perflutren—Nausea—Dexamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Perflutren—Nausea—Betamethasone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Perflutren—Urticaria—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Perflutren—Dizziness—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Perflutren—Vomiting—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Perflutren—Rash—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Perflutren—Dermatitis—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Perflutren—Headache—Prednisone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Perflutren—Asthenia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Perflutren—Nausea—Prednisone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Perflutren—Pruritus—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Perflutren—Dizziness—Methotrexate—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Perflutren—Vomiting—Methotrexate—psoriatic arthritis	0.000937	0.000937	CcSEcCtD
Perflutren—Rash—Methotrexate—psoriatic arthritis	0.000929	0.000929	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—psoriatic arthritis	0.000928	0.000928	CcSEcCtD
Perflutren—Headache—Methotrexate—psoriatic arthritis	0.000923	0.000923	CcSEcCtD
Perflutren—Nausea—Methotrexate—psoriatic arthritis	0.000875	0.000875	CcSEcCtD
